Capsugel's Liquid Dosage Form Technology Utilized by Eight of the Top 10 Pharmaceutical Companies



    CAMBRIDGE, England, Oct. 18 /CNW/ - Capsugel, the leading global provider
of dosage form solutions, announced today that its CFS1000/1200 capsule
filling and sealing machines have now been licensed by eight of the top 10
global pharmaceutical companies. An integral part of the Licaps(R) Drug
Delivery System, these companies are using the CFS1000/1200 capsule filling
and sealing machines in early stage development and manufacturing of Phase 1
clinical trial materials.
    Both the CFS1000 and CFS1200 models eliminate the need for banding
capsules, while providing a secure and impervious capsule seal. By filling and
sealing in one operation, it helps accelerate the development timeframe and
achieve faster time to "First in Man" - the critical Phase 1 go/no go decision
point for new molecules within the pharmaceutical development process.
    Capsugel's Director of Pharmaceutical Technology, David Edwards said
there is a reason for the increased customer interest: ''We see a growing
number of poorly soluble molecules coming through R&D pipelines. The new
CFS1200 facilitates rapid and scaleable development, thereby cutting R&D
timescales and getting drugs into clinical trials as soon as possible. What we
are finding now is that the CFS1200 is proving so invaluable that many
companies are looking to purchase additional machines in order to capitalize
on this unique technology."
    In addition, a number of leading Contract Research Organisations (CROs),
both in the United States and the European Union, have acquired CFS1000/1200
machines. These are being used to service pharmaceutical companies that wish
to evaluate the Licaps drug delivery technology, as well as to provide
additional capacity to those companies who already have the CFS1000/1200
equipment in place.
    The CFS1200 will be on display on the Capsugel stand at the AAPS Annual
Meeting in San Diego, Calif., USA, November 11-15th 2007
(http://www.aapspharmaceutica.com/meetings/annualmeet/am07/index.asp).
    The CFS1200 is also available for demonstrations at Capsugel's sites in
Illkirch, France; Bornem, Belgium; Greenwood, S.C., USA; and Sagamihara,
Japan.

    For further information please visit
http://www.capsugel.com/equipment/cfs1200.php.

    Notes to Editors:

    Capsugel, the world's leading provider of dosage form solutions to the
pharmaceutical and related healthcare industries, is a division of Pfizer Inc.
Offering a diverse array of products and services, Capsugel is at the
forefront of drug delivery innovation. Recent product launches include the
Xcelodose(R) Precision Powder Micro-filling System, which utilizes advanced
technology to better enable R&D scientists to accelerate the pace of drug
development.





For further information:

For further information: Contact for communications and CFS 1200
enquiries: Kate Cartmell, Marketing & Commercial Executive,
kate.a.cartmell@pfizer.com, Capsugel Division of Pfizer, Cambridge Research
Centre, Granta Park, Great Abington, Cambridge CB21 6GB, UK, Tel:
+44-1304-644791, Fax: +44-1223-598070

Organization Profile

CAPSUGEL

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890